Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04268251
Other study ID # AsanMCHSKim_06
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 12, 2020
Est. completion date February 28, 2022

Study information

Verified date May 2024
Source Asan Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Preoperative evaluation of cavernous sinus invasion by pituitary adenoma is critical for performing safe operation and deciding on surgical extent as well as for treatment success. Because of the small size of the pituitary gland and sellar fossa, determining the exact relationship between the pituitary adenoma and cavernous sinus can be challenging. Performing thin slice thickness MRI may be beneficial but is inevitably associated with increased noise level. By applying deep learning based denoising algorithm, diagnosis of cavernous sinus invasion by pituitary adenoma may be improved.


Recruitment information / eligibility

Status Completed
Enrollment 67
Est. completion date February 28, 2022
Est. primary completion date August 30, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing preoperative brain MR for pituitary adenoma Exclusion Criteria: - Patients who have any type of bioimplant activated by mechanical, electronic, or magnetic means (e.g., cochlear implants, pacemakers, neurostimulators, biostimulates, electronic infusion pumps, etc), because such devices may be displaced or malfunction - Patients who are pregnant or breast feeding; urine pregnancy test will be performed on women of child bearing potential - Poor MRI image quality due to artifacts

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
MRI with deep learning based denoising
1-mm coronal contrast-enhanced T1 weighted image with deep learning based denoising

Locations

Country Name City State
Korea, Republic of Asan Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Asan Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

References & Publications (1)

Kim M, Kim HS, Park JE, Park SY, Kim YH, Kim SJ, Lee J, Lebel MR. Thin-Slice Pituitary MRI with Deep Learning-Based Reconstruction for Preoperative Prediction of Cavernous Sinus Invasion by Pituitary Adenoma: A Prospective Study. AJNR Am J Neuroradiol. 2022 Feb;43(2):280-285. doi: 10.3174/ajnr.A7387. Epub 2022 Jan 6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Cavernous sinus invasion Presence or absence of cavernous sinus invasion determined surgically Within 1 week
Secondary Size of pituitary adenoma (in mm), laterality of pituitary adenoma (unilateral or bilateral) on the MRI Size of the tumor (in mm), laterality of the tumor (unilateral or bilateral) on the MRI Within 1 week
Secondary Margin of pituitary adenoma (well-delineated, poorly delineated) on the MRI Margin of pituitary adenoma (well-delineated, poorly delineated) on the MRI Within 1 week